PLUS THERAPEUTICS INC. (PSTV) - Insider Holders & Insider Ownership

List of insiders holdings for PLUS THERAPEUTICS INC.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
#Insider Holder NameReport
Date Time		Shares Owned
Directly
Indirectly		Total
Shares Owned		Filing
1Lim Kian Thiam
10% Owner		2015-04-20 15:27:057,400,000
0		7,400,000Form 4
2OLYMPUS CORP
10% Owner		2014-09-16 06:01:153,973,043
0		3,973,043Form 13D
3PostFinance AG
10% Owner		2018-05-24 16:16:072,795,561
0		2,795,561Form 13G
4HEDRICK MARC H
Chief Executive Officer		2026-01-02 16:30:061,936,593
0		1,936,593Form 4
5Saad Mark E
Chief Financial Officer		2014-04-15 16:03:451,228,430
0		1,228,430Form 4
6SHIRAHAMA NORIO SEIJIRO
President - Asia Pacific		2015-02-03 19:29:24881,159
0		881,159Form 4
7Sims Andrew John Hugh MacIntyre
Chief Financial Officer		2026-01-02 16:30:04489,693
0		489,693Form 4
8COX MARSHALL G
Director		2007-02-28 17:34:31480,000
0		480,000Form 4
9HENRIKSEN RONALD D
Director		2012-01-04 19:12:26438,592
0		438,592Form 4
10Hawkins Richard J
Director		2025-08-15 16:29:10397,794
0		397,794Form 4
11REUTER BRUCE
SVP Sales, Market., Distr.		2009-02-02 16:55:15394,686
0		394,686Form 4
12SCHULZKI SHARON
Chief Operating Officer		2005-02-04 19:20:34380,000
0		380,000Form 4
13Swissquote Bank SA
10% Owner		2018-08-28 11:11:40376,723
0		376,723Form 13G
14Guse Kyle
Director		2025-08-15 16:29:13337,794
0		337,794Form 4
15Clowes Howard
Director		2025-08-15 16:29:08297,794
0		297,794Form 4
16van Es-Johansson An
Director		2025-08-15 16:29:04297,794
0		297,794Form 4
17GALETTO CHARLES
Sr. Vice President Finance & A		2006-01-26 16:56:35280,000
0		280,000Form 4
18Arm Douglas M
Sr. VP - Operations		2009-05-04 20:33:40185,000
0		185,000Form 4
19SCARBROUGH ELIZABETH
Vice President Marketing & Dev		2006-01-26 17:16:02176,250
0		176,250Form 4
20FRASER JOHN K
Vice President Research & Tech		2005-02-04 16:46:59166,250
0		166,250Form 4
21SCOTT MATTHEW
Vice President Sales		2004-06-04 17:46:43165,000
0		165,000Form 4
22Milstein Alexander M
VP - Clinical Development		2009-02-02 16:57:24155,000
0		155,000Form 4
23CALHOUN CHRISTOPHER J
Chief Executive Officer		2014-01-14 18:11:01118,125
36,850		154,975Form 4
24Townsend John
Controller		2015-02-03 19:30:39139,850
0		139,850Form 4
25Lenk Robert P
Director		2025-08-25 07:30:05139,327
0		139,327Form 4
26Thompson Tommy G
Director		2016-01-04 17:55:54136,950
0		136,950Form 4
27Ransom John T
VP Research Regn. Cell Techn.		2007-02-28 18:00:20105,000
0		105,000Form 4
28Dean Lloyd H
Director		2014-05-20 12:17:0551,059
40,000		91,059Form 4
29HOLMES E CARMACK
Director		2014-05-20 12:09:1219,517
37,401		56,918Form 4
30LAPOINTE ANTHONY GREGG
Director		2017-05-24 16:35:4550,000
0		50,000Form 4
31MARTELL RON
Director		2017-01-27 17:46:0950,000
0		50,000Form 4
32Jona Ruud J.P.
Director		2014-06-12 16:25:5342,000
0		42,000Form 4
33Petersen Greg
Director		2025-02-20 17:30:0340,122
0		40,122Form 4
34Marino Mark
Chief Medical Officer		2017-03-17 17:10:4831,100
0		31,100Form 4/A
35HAYDEN JEREMY B.
General Counsel & VP of BD		2017-03-17 17:08:1931,100
0		31,100Form 4/A
36HAWRAN PAUL W
Director		2017-01-27 17:48:4325,000
0		25,000Form 4
37LaFrance Norman D.
Chief Medical Officer		2024-02-26 18:26:3124,073
0		24,073Form 4
38RICKEY DAVID
Director		2017-11-29 17:40:0710,806
0		10,806Form 4
39KESTEN STEVEN
Exec VP and Chief MO		2016-06-15 18:56:213,581
400		3,981Form 4
40LYONS GARY A
Director		2018-02-09 16:54:031,801
0		1,801Form 4
41HARRIS JOHN DAVID
VP and GM Cell Therapy		2017-11-29 17:34:411,801
0		1,801Form 4
42Naughton Gail K
Director		2017-11-29 17:39:061,801
0		1,801Form 4
43Girao Tiago
VP & Chief Financial Officer		2018-07-27 16:31:451,051
0		1,051Form 4